Insmed, Inc. (INSM) vs Regeneron Pharmaceuticals, Inc. (REGN)

Insmed, Inc. and Regeneron Pharmaceuticals, Inc. are both Biotechnology companies. Regeneron Pharmaceuticals, Inc. is the larger, with a market value of $81.3B against $26.8B — 3.0× the size. Insmed, Inc. has negative trailing earnings, so its P/E is not meaningful; Regeneron Pharmaceuticals, Inc. trades at 18.8×. Insmed, Inc. grew revenue faster over the last twelve months: 185.8% against 9.29%. Regeneron Pharmaceuticals, Inc. has the higher net margin (27.9% vs −76.9%) and the higher return on invested capital (9.34% vs −329.2%). Across the 19 metrics below, Regeneron Pharmaceuticals, Inc. leads on 16 and Insmed, Inc. on 3.